2[2]Avery GB,Fletcher MA,MacDonald MG.Neonatology pathophysiology & management of the newborn.5th ed.Philadelphia:Lippincott Williams & Wilkins,1999.509
3[5]Lyon A.Chronic lung disease of prematurity:the role of intra-uterine infection.Eur J Pediatr,2000,159:798
4[6]De Dooy JJ,Mahieu LM,Van Bever HP.The role of inflammation in the development of chronic lung disease in neonates.Eur J Pediatr,2001,160:457
5[8]Halliday HL,Ehrenkranz RA,Doyle LW.Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.Cochrane Database Syst Rev,2003(1):CD001145
6[9]Groneck P.Perinatal glucocorticosteroid therapy:time for reconsideration.Z Geburtshilfe Neonatol,2001,205(6):231
7[10]LeFlore JL,Salhab WA,Broyles RS,et al.Association of antenatal and postnatal dexamethasone exposure with outcomes in extremely low birth weight neonates.Pediatrics,2002,110(2 Pt 1):275
8[1]Committee on Fetus and Newborn of American Academy of Pediatrics:use of inhaled nitric oxide. Pediatrics,2000,106:344
9[2]Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and near full-term infants with hypoxic respiratory failure. N Engl J Med,1997,336:597
10[3]Neonatal Inhaled Nitric Oxide Study Group (NINOS). Inhaled nitric oxide in full-term and near full-term infants:neurodevelopmental follow-up of the Neonatal Inhaled Nitric Oxide Study Group (NINOS). J Pediatr,2000,136:611
